Results 171 to 180 of about 52,426 (262)
Back to School after Corona Virus Disease of 2019: New Relationships, Distance Schooling, and Experienced Routine. [PDF]
Pediconi MG, Brunori M, Romani S.
europepmc +1 more source
The Bidirectional Association Between MASLD and Male Hypogonadism: An Updated Meta‐Analysis
ABSTRACT Background Metabolic dysfunction‐associated steatotic liver disease (MASLD) and male hypogonadism are increasingly prevalent, metabolically interrelated conditions. Testosterone (T) deficiency has been implicated in hepatic lipid dysregulation, insulin resistance, and visceral adiposity, whereas MASLD may impair the hypothalamic–pituitary ...
Giorgia Spaggiari +9 more
wiley +1 more source
Nebulization of Mesenchymal Stem Cells Secretome Attenuates Acute Respiratory Distress Syndrome Caused by SARS-CoV-2 Corona Virus: An Open-Label, Controlled Trial. [PDF]
Baghalishahi M +5 more
europepmc +1 more source
The effect of Psidium guajava Leaves' extract for mild and asymptomatic corona virus Disease-19. [PDF]
Heppy F +3 more
europepmc +1 more source
Current research reports that micro‐nanoplastics may increase the burden of cardiovascular disease with significant human and economic consequences. The detection of plastic particles in biological matrices is challenging and rigorous research is required to investigate the clinical and broader public health implications of microplastics.
Adrian Goldsworthy +4 more
wiley +1 more source
Community responses to corona virus disease (COVID-19) in Africa in the face of "Infodemic": A scoping review. [PDF]
Muhanga M, Jesse A, Ngowi E.
europepmc +1 more source
ABSTRACT Aim This pilot study explored signs of immunological cross‐reactivity between SARS‐CoV‐2 and human coronaviruses (HCoVs) in a Swedish school setting. Methods A cross‐sectional, hypothesis‐generating study was conducted late 2020 before vaccines against COVID‐19 were available.
Lina Schollin Ask +14 more
wiley +1 more source
Clinical Burden of Symptomatic HEV‐3 Infection in Southern Spain
Clinical burden of symptomatic HEV‐3 infection in southern Spain. Between 2022 and 2025, 1124 patients with acute hepatitis, defined as ALT ≥ 3 times the upper limit of normal and negative screening for HAV, HBV, HCV, EBV and CMV, were evaluated in Andalusia.
María Casares‐Jimenez +14 more
wiley +1 more source

